Explore 6 job-ready courses from Great Learning Academy Pro+ in collaboration with Microsoft. Learn Excel, SQL, Power BI, and ...

Two parallel experiments in protein self-assembly produced strikingly different results, demonstrating that protein designers ...

AI has dominated commercial conversations for the past year. Nearly every major enterprise software vendor has announced an AI agent strategy, boards are asking how AI will boost productivity and, ...

Abstract: The effectiveness of dimension reduction analysis for high-dimensional process data is crucial to ensure industrial safety. Manifold learning methods can be advanced by considering both ...

Enterprises still struggle to align governance, analytics, and AI despite years of data investment — that’s because what they really need is a structural reset of the data core itself that would unify ...

Clinical research is evolving rapidly. Trials are more complex, data sources keep expanding, and regulators expect greater transparency and reproducibility. In parallel, AI is transforming how data is ...

Our region has reduced vulnerabilities in the language and cognitive development domain, according to the Early Development Instrument (EDI). As a community, can we argue that our collective efforts ...

Latest appointment further strengthens Align’s ability to deliver seamless, large-scale data center solutions across the U.S. Align, a premier global provider of technology infrastructure solutions, ...

When voters move from emotional frustration to causal reasoning, elections follow. What’s also notable is what didn’t happen. Despite intense media coverage of foreign crises – Gaza, Syria, Venezuela ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...